Member Info for johnlaycock

Roger, who do you know BR is definitely going to be abolished? Do you work in the Treasury??

I suspect that the vast majority of the companies shareholders are not holders for inheritance tax planning reasons, so if it is abolished, I would hope there would not be a huge sell off esp ahead of hopefully good news the next day??

NHS going to get a big increase in Wednesdays budget with emphasis on embracing the latest technologies = genedrive

Https://www.ftadviser.com/investments/2024/10/23/business-property-relief-unlikely-to-be-removed-from-aim-shares/

Agreed Stephen. With a big week ahead for the company and positive news flow due, its a shame we can't focus on that instead.

Let's hope that Rachel Reeves has leant from the Liz Truss disastrous budget!

A decent RNS and 2.8p will be history.

Lots of positive news due though on various fronts but I do think the company will be taken out before too long. It would be the most sensible way to get their two tests to market quicker than soldering along on their own.

Totally irrelevant news....the Chairman has sold companies for hundreds of millions, so he knows what he is doing (hence his buy in August was very significant positive signal).

Https://www.emqn.org/emqn-launches-new-eqa-scheme-for-mt-rnr1-point-of-care-testing-poct-for-use-with-the-genedrive-mt-rnr1-system/

Dont forget 31st October also sees the STG report into genotype testing to prevent hearing loss in babies so not just around stroke testing,

https://shtg.scot/our-advice/genotype-testing-to-guide-antibiotic-use-and-prevent-hearing-loss-in-babies/

Slacker it was not a bombshell RNS at all as it just confirmed the provisional recommendation of stroke testing (both lab and PCT) earlier in the year. It was a significant milestone for the company esp as their test was confirmed as the preferred PCT and they also stated it could be used in lab settings

Lionel, thanks for posting the positive update re Salford but reading more closely it suggests the pilot will be based on lab testing not PCT. Or have I misread? Hopefully the company is busy selling direct to Labs anyhow.

It was not the CEO who recently bought in, but the Chair.

Roger, you said you had rebought in last week (despite previously claiming you wouldn't until the next RNS). Are you holding or have you sold out again?

Porky thanks a good analysis but as per option 4, I think the tech has proved to be unique and first class and as per the recent NICE recommendations is very much wanted.

I think (hope) we are due lots of positive news now which should massively improve the SP....FDA, Scottish report x2, stroke pilot roll out etc etc

Tope started in August when it was also discussed on this board!

Stephen, a good summary. The SHTG reports have now been delayed until Oct 31st. Original publication was Sept 30th, then it was delayed to 17th Oct. Now 31st Oct.

What work Joey?